BRANDIE EDGMAN: Open Payments
NPI 1831871292 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,199 in 75 payments from 15 companies in 2025. Trend: 2023 $354 · 2024 $1,109 · 2025 $1,199
Food & beverage: $1,099Education: $100
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 37 | $316 |
| Janssen Biotech, Inc. | 11 | $252 |
| IMMUNITYBIO, INC. | 2 | $137 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $84 |
| Astellas Pharma US Inc | 3 | $59 |
| PFIZER INC. | 3 | $55 |
| UROGEN PHARMA, INC. | 2 | $48 |
| TOLMAR, INC. | 2 | $48 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $45 |
| Novartis Pharmaceuticals Corporation | 2 | $36 |
Products named: ORGOVYX, ERLEADA, ANKTIVA, Xtandi, Nubeqa, JATENZO, JOURNAVX, PLUVICTO.
Industry payments across NE — which companies pay providers there.
